Navigation Links
Omeros Files Orphan Drug Application for Treatment of Atypical Hemolytic Uremic Syndrome with OMS721
Date:4/17/2013

20-minute to two-hour intravenous infusion in a medical facility, while OMS721 is designed to be self-administered by subcutaneous injection, which would be more convenient for patients.

"We believe that OMS721 meets the criteria for orphan drug designation, representing a significant therapeutic advance over currently available treatments for aHUS," stated Gregory A. Demopulos , M.D., chairman and chief executive officer of Omeros. "We plan to file for the same designation in Europe, and we remain on track to begin clinical trials early this summer. The potential indications for OMS721 span a wide range of attractive markets in both orphan and highly prevalent diseases, and we are excited to evaluate its efficacy in patients."

About Orphan Drug Status

Orphan drug designation is granted by the FDA's Office of Orphan Products Development for treatments that are expected to provide significant therapeutic advantage over existing treatments and that target conditions affecting 200,000 or fewer U.S. patients per year. Orphan drug designation qualifies a company for several benefits under the Orphan Drug Act of 1983. The benefits apply across all stages of drug development and include accelerated approval process; seven years of market exclusivity following marketing approval; tax credits on U.S. clinical trials; eligibility for orphan drug grants; and waiver of certain administrative fees.

About Omeros' MASP-2 Program

Omeros controls the worldwide rights to MASP-2 and all therapeutics targeting MASP-2, a novel pro-inflammatory protein target involved in activation of the complement system, which is an important component of the immune system. The complement system plays a role in the inflammatory response and becomes activated as a result of tissue damage or microbial infection. MASP-2 appears to be unique to, and required for the function of, one of the principal complement acti
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Omeros Announces that GPR17 Antagonists Improve Function in Model of Multiple Sclerosis
2. Omeros Announces Positive OMS721 Data in Model of Thrombotic Microangiopathy
3. Omeros to Present at the 2013 Future Leaders in the Biotech Industry Conference
4. Omeros Announces Toxicology Data that Support Advancing MASP-2 Inhibitor into Clinical Trials
5. Omeros Announces Successful Completion of PDE10 Phase 1 Multiple Ascending Dose Trial
6. Omeros Elucidates Mechanism of its PDE7 Inhibitors in Addiction
7. Omeros to Present at the Cowen and Company 33rd Annual Health Care Conference
8. Omeros Announces Toxicology Study Data from MASP-2 Inhibitor
9. Omeros Announces Positive OMS302 Safety Data in Phase 3 Clinical Trial
10. Omeros Announces Encouraging Data from Phase 1 Clinical Trial for PDE10 Program
11. Omeros to Present at the 24th Annual Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 25, 2014  CVS Caremark Corporation (NYSE: ... Tuesday, August 5, 2014, at 8:30 a.m. (EDT) with ... financial results. An audio webcast of the ... Relations portion of the CVS Caremark website for all ... . This webcast will be archived and available on ...
(Date:7/25/2014)... -- Solanbridge Group Inc (OTC: SLNX) is pleased to announce ... and the Letter of Intent issued on July 11, ... Agreement. Charles R. Shirley , Managing ... Mr. David Pecoraro and Buzznbrewz.com join SLNX,s ... sector and developed a tremendous network of contacts who ...
(Date:7/25/2014)...  AMETEK, Inc. (NYSE: AME ) today ... as Vice President and General Manager, Engineered Medical Components, ... "I am pleased that Kurt has joined ... experience, especially in the medical device industry, and we ... growth and success of our medical components businesses," commented ...
Breaking Medicine Technology:Solanbridge Group Inc Announces Acquisition of Buzznbrewz.com 2AMETEK Names Kurtis L. Goos, Vice President & General Manager, Engineered Medical Components 2
... Intensive Blood Sugar Control Are, Not Statistically Significant but Show Favorable Trend ... ... Events, SAN FRANCISCO, June 8 Findings from the Veterans,Affairs Diabetes ... diabetes patients were,released today at the 68th Scientific Sessions of the American ...
... the ... Diabetes Association, SAN FRANCISCO, June 7 Amylin Pharmaceuticals,Inc. (Nasdaq: ... and Alkermes, Inc.,(Nasdaq: ALKS ) announced results from a 30-week ... formulation of,exenatide, to BYETTA(R) (exenatide) injection. Type 2 diabetes patients,treated with ...
Cached Medicine Technology:Large, Long-Term Veterans Affairs Diabetes Trial (VADT) Reveals Important Cardiovascular Safety News on AVANDIA(R) 2Large, Long-Term Veterans Affairs Diabetes Trial (VADT) Reveals Important Cardiovascular Safety News on AVANDIA(R) 3Large, Long-Term Veterans Affairs Diabetes Trial (VADT) Reveals Important Cardiovascular Safety News on AVANDIA(R) 4Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight 2Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight 3Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight 4Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight 5Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight 6Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight 7Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight 8
(Date:7/25/2014)... 25, 2014 As reported by People Magazine ... After Jersey Shore and Getting Sober (7/15), one of ... Shore, has spoken out to the public about his personal ... show, The Situation admits that moving on with his life ... drugs, and other drugs in 2012 and even spent some ...
(Date:7/25/2014)... News) -- The human brain can preserve oxygen to ... study finds. Although dehydration significantly reduces blood ... that the brain compensates by increasing the amount of ... has helped us understand a lot more about how ... conditions," study first author Steven Trangmar, a researcher at ...
(Date:7/25/2014)... July 25, 2014 Art of Facial Surgery ... to those in Toronto who are looking for minor touch-ups ... study done by the American Academy of Facial Plastic and ... interest in facial plastic surgery showed a surprising increase between ... 10 percent, while hair transplants increased by 7 percent and ...
(Date:7/25/2014)... 2014 A new study of participants in ... are published today in Cancer , found evidence that ... who had an abnormal finding on a lung cancer screening ... life than did those who were screened and found to ... to the researchers. “We expected that participants with an abnormal ...
(Date:7/25/2014)... 2014(BRONX, NY)A study involving nearly 27,000 older adults on ... criteria for pre-dementia based on a simple test that ... cognitive complaints. People who tested positive for pre-dementia were ... 12 years. The study, led by scientists at ... and Montefiore Medical Center , was published online ...
Breaking Medicine News(10 mins):Health News:'The Situation' Celebrates 8 Months of Sobriety 2Health News:'The Situation' Celebrates 8 Months of Sobriety 3Health News:Human Brain Has Coping Mechanism for Dehydration 2Health News:Art of Facial Surgery Responds to Demand for Facial Plastic Surgery Increase Due to the Popularity of Selfies 2Health News:Art of Facial Surgery Responds to Demand for Facial Plastic Surgery Increase Due to the Popularity of Selfies 3Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 2Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 3Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 4Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 5Health News:Slow walking speed and memory complaints can predict dementia 2Health News:Slow walking speed and memory complaints can predict dementia 3Health News:Slow walking speed and memory complaints can predict dementia 4
... on sodas, other sweet beverages may work better than eating ... When it comes to losing weight, cutting back on the ... important. , So say researchers who found that cutting back ... per day -- accounted for nearly two-and-a-half pounds of ...
... In a press conference today, Colgate and,the Hispanic ... Salud,Bucal: Un Mundo de Sonrisas Saludables (Oral Health Month: ... commitment to quality oral care among the,Hispanic community. , ... lack of familiarity accessing oral,healthcare services, among other factors, ...
... (Nasdaq: MEDQ ), a leading provider of ... final judgment approving settlement and dismissing the consolidated medical ... of the results of the internal review of its ... about its workforce, and throughout this litigation the Company ...
... Company Reports Earnings per Share of 9 cents ... April 2 Allscripts-Misys Healthcare Solutions, Inc. (Allscripts) ... and nine months ended February 28, 2009. (Logo: ... months ended February 28, 2009 include results of ...
... of a Big Brothers Big Sisters of America ... women mentors, revealed that strong emotional support and ... was a dominant theme coupled with the development ... , Unlike previous mentoring studies, this one explicitly ...
... April 2 Varian Medical Systems (NYSE: ... a mid-year review for investors from noon through 2 p.m. ... hotel located at 1 Avenue De Lafayette. Management presentations ... year 2009, strategic initiatives, and growth opportunities in markets for ...
Cached Medicine News:Health News:Fewer Sugary Drinks Key to Weight Loss 2Health News:Fewer Sugary Drinks Key to Weight Loss 3Health News:Colgate and the Hispanic Dental Association Proclaim April El Mes de la Salud Bucal to Promote Oral Health Fundamentals Among Hispanics 2Health News:Colgate and the Hispanic Dental Association Proclaim April El Mes de la Salud Bucal to Promote Oral Health Fundamentals Among Hispanics 3Health News:MedQuist Announces Entry of Final Judgment Approving Settlement and Dismissing Medical Transcriptionist Class Action 2Health News:MedQuist Announces Entry of Final Judgment Approving Settlement and Dismissing Medical Transcriptionist Class Action 3Health News:Allscripts Reports Fiscal 2009 Third Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Third Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Third Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Third Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Third Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Third Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Third Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Third Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Third Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Third Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Third Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Third Quarter Results 13Health News:Allscripts Reports Fiscal 2009 Third Quarter Results 14Health News:Gaining new insights into mentoring programs for adolescent girls 2Health News:Gaining new insights into mentoring programs for adolescent girls 3Health News:Varian Medical Systems Schedules Mid-Year Review With Investors in Boston 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: